Hillcrest Expands Equipmake Talks to Include Commercial Licensing of ZVS Tech
HLRTF sits 46% above its 52-week low of $0.06.
Summary
Hillcrest and Equipmake have expanded their partnership negotiations to include commercial licensing terms for Hillcrest's ZVS inverter technology, moving beyond the original joint development scope. The companies now aim to sign a single definitive agreement covering both development and commercialization, with completion expected in October 2026. This follows the July 9 LOI and a September 29 peer-reviewed validation of the technology's performance. The expanded scope signals stronger commercial intent and a clearer path to revenue, though terms remain unfinalized and execution is not guaranteed.
At the time of this announcement, HLRTF was trading at $0.09 on OTC in the Energy & Transportation sector, with a market capitalization of approximately $18.3M. The 52-week trading range was $0.06 to $0.17. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: ACCESS Newswire.